Policy Implications of Gene Editing and Biotechnology Regulation

Abstract

Gene editing and biotechnology represent transformative advancements with profound potential to reshape medicine, agriculture, and environmental management. However, their rapid development poses significant regulatory and ethical challenges that require comprehensive policy frameworks. This chapter explores the policy implications surrounding gene editing technologies, such as CRISPR, highlighting the balance between fostering innovation and ensuring public safety, ethical standards, and equitable access. It discusses regulatory approaches adopted worldwide, the role of international cooperation, and the socio-political dynamics influencing governance. By examining current legislative landscapes and emerging best practices, the chapter aims to inform policymakers, legal scholars, and industry stakeholders about effective governance models that align with ethical imperatives and technological progress.